7 Results for "

KHOS

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "KHOS" in MCE Product Catalog:

Cat. No.: HY-132302
CAS No.: 2360523-76-6
Purity:  99.91%
Research Areas:  

Cancer

Hu7691 is an orally active, selective Akt inhibitor with IC50s of 4.0 nM, 97.5 nM, 28 nM for Akt1, Akt2 and Akt3, respectively. Hu7691 inhibits tumor growth and enables decrease of cutaneous toxicity in mice .
loading...
    loading...
Cat. No.: HY-N6611
CAS No.: 482-70-2
Chimaphilin is an IGF-1R inhibitor (IC50: 0.086 μM). Chimaphilin has antifungal, antioxidant and anticancer activities. Chimaphilin inhibits the growth of both drug-sensitive and drug-resistant osteosarcoma cell lines. Chimaphilin can induce cancer cell apoptosis. Chimaphilin is a main component of pyrola .
loading...
    loading...
Cat. No.: HY-P990282

Research Areas:  

Cancer

Anti-Mouse CD24 Antibody (M1/69) is a rat-derived anti-mouse CD24 IgG2b κ type antibody inhibitor. Anti-Mouse CD24 Antibody reduces heat stable antigen (HSA) expression level and delays wound healing in Wild-type HSA +/+ mice .
loading...
    loading...
Cat. No.: HY-132302A
CAS No.: 2241232-43-7
Research Areas:  

Cancer

Hu7691 free base is an orally active, selective Akt inhibitor with IC50s of 4.0 nM, 97.5 nM, 28 nM for Akt1, Akt2 and Akt3, respectively. Hu7691 free base inhibits tumor growth and enables decrease of cutaneous toxicity in mice .
loading...
    loading...
Cat. No.: HY-125158
CAS No.: 1451013-67-4
Target:  

Aurora Kinase Apoptosis

Research Areas:  

Cancer

HOI-07 is a selective Aurora B kinase inhibitor. HOI-07 blocks phosphorylation of histone H3 on Ser10 in lung cancer cells. HOI-07 induces cell-cycle arrest, and apoptosis. HOI-07 has antitumor activity, and suppresses the tumor growth of A549, 143B and KHOS xenografts .
loading...
    loading...
Cat. No.: HY-161417
CAS No.: 2747216-27-7
Target:  

LIM Kinase (LIMK)

Research Areas:  

Cancer

LIMK-IN-2 (Compound 52) is an LIMK inhibitor. LIMK-IN-2 can suppress the cell migration of osteosarcoma and cervical cancer cells, demonstrating potential anti-angiogenic activity .
loading...
    loading...
Cat. No.: HY-182764
Target:  

CDK

Research Areas:  

Cancer

CDK11-IN-1 is an orally active cyclin-dependent kinase 11 (CDK11) inhibitor with high selectivity against other kinases including CDK7 and CDK9. CDK11-IN-1 inhibits tumor growth in lung cancer xenograft models. CDK11-IN-1 can be used for lung cancer research .
loading...
    loading...